首页> 外文期刊>Head and neck: Journal for the sciences and specialities of the head and neck >Transoral laser microsurgery in treatment of pT2 and pT3 glottic laryngeal squamous cell carcinoma - Results of 391 patients
【24h】

Transoral laser microsurgery in treatment of pT2 and pT3 glottic laryngeal squamous cell carcinoma - Results of 391 patients

机译:经口激光显微手术治疗pT2和pT3声门喉喉鳞状细胞癌-391例结果

获取原文
获取原文并翻译 | 示例
           

摘要

Background. The purpose of this study was to evaluate oncological and functional results of transoral laser microsurgery (TLM) in patients with T2 and T3 glottic laryngeal squamous cell carcinoma (SCC). Methods. A retrospective chart analysis was carried out. Cases were classified into categories pT2a, pT2b, and pT3. Treatment was exclusively TLM ± selective neck dissection and adjuvant (chemo)radiotherapy. Results. Three hundred ninety-one patients were treated by TLM; 142 cases were category pT2a, 127 were pT2b, and 122 were pT3. Median follow-up was 71 months. Five-year overall, recurrence-free, and disease specific survival rates were 72.2%, 76.4%, and 93.2% for pT2a tumors, 64.9%, 57.3%, and 83.9% for pT2b tumors, and 58.6%, 57.8%, and 84.1% for pT3 tumors, respectively. Larynx preservation was achieved in 93% (pT2a) and 83% (pT2b and pT3). Conclusion. Results are comparable to open partial or total laryngectomy and superior to primary (chemo)radiotherapy. TLM results in a lower morbidity and superior function compared to standard treatment.
机译:背景。这项研究的目的是评估经口激光显微外科手术(TLM)对T2和T3声门喉喉鳞状细胞癌(SCC)患者的肿瘤学和功能结果。方法。进行了回顾性图表分析。病例分为pT2a,pT2b和pT3类别。治疗仅采用TLM±选择性颈淋巴清扫术和辅助(化学)放疗。结果。 TLM治疗了391例患者。 pT2a类别为142例,pT2b为127例,pT3为122例。中位随访时间为71个月。 pT2a肿瘤的五年总体无复发生存率和疾病特异性生存率分别为72.2%,76.4%和93.2%,pT2b肿瘤为64.9%,57.3%和83.9%,分别为58.6%,57.8%和84.1。 pT3肿瘤分别为%。 93%(pT2a)和83%(pT2b和pT3)的喉部保存率达到了。结论。结果与开放式部分或全部喉切除术相当,并且优于初级(化学)放射治疗。与标准治疗相比,TLM的发病率更低,功能更优越。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号